Frykholm, G J <br/><br/>
Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jun 2001 
 - 427-34 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(01)01479-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Radiotherapy--adverse effects<br/>Rectal Neoplasms--drug therapy<br/>Survival Rate